Oarsman Capital, Inc. Gilead Sciences, Inc. Transaction History

Oarsman Capital, Inc.

$562 Million
Q4 2024

A detailed history of Oarsman Capital, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Oarsman Capital, Inc. holds 350 shares of GILD stock, worth $35,983. This represents 0.01% of its overall portfolio holdings.

Number of Shares

350

Previous 491 28.72%

Holding current value

$35,983

Previous $41,000 21.95%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$83.95 - $97.9 $11,836 - $13,803	-141 Reduced 28.72%	350 $32,000
Q3 2024 Nov 08, 2024	BUY	$66.59 - $83.99 $32,695 - $41,239	491 New	491 $41,000
Q1 2021 May 12, 2021	SELL	$60.0 - $68.46 $211,500 - $241,321	-3,525 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $15,295 - $17,428	-270 Reduced 7.11%	3,525 $205,000
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $7,762 - $9,760	-125 Reduced 3.19%	3,795 $240,000
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $40,799 - $47,376	564 Added 16.81%	3,920 $302,000
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $107,097 - $137,176	-1,710 Reduced 33.75%	3,356 $251,000
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $49,604 - $54,562	-805 Reduced 13.71%	5,066 $329,000
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $27,066 - $29,877	-433 Reduced 6.87%	5,871 $372,000
Q2 2019 Aug 13, 2019	SELL	$61.87 - $69.38 $28,707 - $32,192	-464 Reduced 6.86%	6,304 $426,000
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $1.27 Million - $1.42 Million	-20,249 Reduced 74.95%	6,768 $440,000
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $171,146 - $223,333	-2,827 Reduced 9.47%	27,017 $1.69 Million
Q3 2018 Nov 07, 2018	SELL	$71.28 - $78.92 $54,315 - $60,137	-762 Reduced 2.49%	29,844 $2.3 Million
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $130,927 - $152,722	-2,018 Reduced 6.19%	30,606 $2.17 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $105,253 - $128,316	-1,445 Reduced 4.24%	32,624 $2.46 Million
Q4 2017 Feb 08, 2018	SELL	$71.15 - $83.52 $102,313 - $120,101	-1,438 Reduced 4.05%	34,069 $2.44 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $2.56 Million - $3.03 Million	35,507	35,507 $2.88 Million

Others Institutions Holding GILD

# of Institutions

2,203

Shares Held

992M

Call Options Held

8.66M

Put Options Held

9.39M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $129B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oarsman Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oarsman Capital, Inc. with notifications on news.

Account

Oarsman Capital, Inc. Gilead Sciences, Inc. Transaction History